Adma Biologics, Inc.

File a Biologics License Application for the Myrtle Beach plasma collection facility

Deadline passed; outcome being checked

Announced: 16 Nov 2021
Due: 16 Feb 2022
Status: Checking

Deadline
Met
Late
Not met
Today

What the company said

“ADMA expects to file its BLA for the Myrtle Beach, South Carolina plasma collection facility in approximately three months”

SourceAdma Biologics, Inc. Form 8-K press release, 2021-11-16
FilingSEC filing index
Deadline as statedin approximately three months
Deadline used16 Feb 2022, the last day of the stated period
TypeRegulatory
Permanent referenceKI-C-2021-ADMA-003410
Cite as https://keptindex.org/c/KI-C-2021-ADMA-003410/ — this address never changes.

What we found

The deadline has passed. We check for public evidence starting 30 days after the deadline, and repeat the check if nothing clear turns up.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type: Regulatory submission
Indicative materiality: High rules
Action: File
Deliverable: Biologics License Application for Myrtle Beach facility
Where: Myrtle Beach, South Carolina
Language: Expected (“expects”, “plans”)
In the company’s control: High
Specificity: High
Depends on: Regulatory

Tell me what happens

This deadline has not been settled yet. We check 30 days after it passes. Get an email when we record the outcome.

Alert me when this resolves

How this entry was checked

Commitment recordedThe company's words were matched word for word against the filing.
OutcomeNot yet assessed. Nothing is judged before the deadline.

Are you Adma Biologics, Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-ADMA-003410 · Corrections policy